Baar, Switzerland

Jae Kyoung Pak

This inventor holds 1 USPTO granted patent. Top assignee: Mallinckrodt, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Kyoung Pak. Retrieved from https://idiyas.com/inventor/jae-kyoung-pak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jae Kyoung Pak: Innovator in Biomolecular Labeling

Introduction

Jae Kyoung Pak is a notable inventor based in Baar-Inwil, Switzerland. She has made significant contributions to the field of biomolecular labeling through her innovative work.

Latest Patents

Jae Kyoung Pak holds one patent related to novel histidine derivatives. This invention pertains to the labeling of biomolecules with radioactive metal tricarbonyls. The new derivatives feature a histidine that is derivatized at the N and at least protected at the N, with various options for additional derivatization and protection.

Career Highlights

Jae Kyoung Pak is currently employed at Mallinckrodt, Inc., where she continues to advance her research and development efforts. Her work focuses on enhancing the capabilities of biomolecular labeling techniques.

Collaborations

Jae Kyoung Pak collaborates with her coworker, Roger Alberto, who contributes to their shared projects and research initiatives.

Conclusion

Jae Kyoung Pak's innovative work in biomolecular labeling showcases her expertise and dedication to advancing scientific research. Her contributions are valuable to the field and highlight the importance of innovation in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…